Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
UCLA Medical Center
mi
from
Los Angeles, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
UC Davis Medical Center
mi
from
Sacramento, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
UC Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
UCSF Medical Center
mi
from
San Francisco, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
UCSF Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
California Pacific Medical Center
mi
from
San Francisco, CA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Colorado Health Science Center
mi
from
Aurora, CO
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Colorado Health Science Center
mi
from
Aurora, CO
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
MedStar Washington Hospital Center
mi
from
Washington,
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Florida
mi
from
Gainesville, FL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Miami
mi
from
Miami, FL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Lifelink Healthcare Institute
mi
from
Tampa, FL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Lifelink Healthcare Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Piedmont Hospital
mi
from
Atlanta, GA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Piedmont Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Emory University
mi
from
Atlanta, GA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Illinois, Chicago
mi
from
Chicago, IL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Illinois, Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Rush University
mi
from
Chicago, IL
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Kansas Medical Center
mi
from
Kansas City, KA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Maryland
mi
from
Baltimore, MD
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Johns Hopkins University
mi
from
Baltimore, MD
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Michigan
mi
from
Ann Arbor, MI
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Saint Barnabas Medical Center
mi
from
West Orange, NJ
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Saint Barnabas Medical Center
mi
from
West Orange, NJ
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Columbia University
mi
from
New York, NY
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Cornell University
mi
from
New York, NY
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Duke University
mi
from
Durham, NC
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Cincinnati Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
The Christ Hospital
mi
from
Cincinnati, OH
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
The Christ Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Pittsburgh
mi
from
Pittsburgh, PA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Medical University of South Carolina
mi
from
Charleston, SC
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Baylor University Medical Center
mi
from
Dallas, TX
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Baylor All Saints Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Houston Methodist Hospital
mi
from
Houston, TX
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Virginia
mi
from
Charlottesville, VA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
Virginia Commonwealth University (MCV)
mi
from
Richmond, VA
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
Virginia Commonwealth University (MCV)
mi
from
Richmond, VA
Click here to add this to my saved trials
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated:  12/11/2012
University of Wisconsin
mi
from
Madison, WI
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation
Status: Enrolling
Updated: 12/11/2012
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Status: Enrolling
Updated:  12/11/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH
Status: Enrolling
Updated: 12/11/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  1/4/2013
Clinical Research Facility
mi
from
Miami, FL
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 1/4/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  1/4/2013
Clinical Research Facility
mi
from
Orlando, FL
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 1/4/2013
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  1/4/2013
Clinical Research Facility
mi
from
Neptune, NJ
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
A Phase 1, Open-Label, Parallel-Cohort, Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 1/4/2013
Clinical Research Facility
mi
from
Neptune, NJ
Click here to add this to my saved trials
Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function
A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function
Status: Enrolling
Updated:  1/9/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function
A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function
Status: Enrolling
Updated: 1/9/2013
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
A Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Normal Renal Function and Subjects With Moderate-to-Severe Renal Impairment With Non-Dialysis-Dependent Renal Insufficiency (NDDRI)
Status: Enrolling
Updated:  1/9/2013
Avail Clinical Research
mi
from
DeLand, FL
Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
A Pharmacokinetic, Pharmacodynamic, and Safety Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Normal Renal Function and Subjects With Moderate-to-Severe Renal Impairment With Non-Dialysis-Dependent Renal Insufficiency (NDDRI)
Status: Enrolling
Updated: 1/9/2013
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin
Status: Enrolling
Updated:  1/11/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin
Status: Enrolling
Updated: 1/11/2013
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Seattle Cardiorenal Remote Ischemic Preconditioning Trial
Effect of Remote Ischemic Preconditioning in Children Undergoing Cardiac Surgery
Status: Enrolling
Updated:  1/15/2013
Seattle Children's Hospital
mi
from
Seattle, WA
Seattle Cardiorenal Remote Ischemic Preconditioning Trial
Effect of Remote Ischemic Preconditioning in Children Undergoing Cardiac Surgery
Status: Enrolling
Updated: 1/15/2013
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Status: Enrolling
Updated:  1/22/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Outlook: An Intervention to Improve Quality of Life in Serious Illness
Status: Enrolling
Updated: 1/22/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Targeting Social Determinants to Improve Chronic Kidney Disease Care
Targeting Social Determinants to Improve Chronic Kidney Disease Care
Status: Enrolling
Updated:  1/22/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
Targeting Social Determinants to Improve Chronic Kidney Disease Care
Targeting Social Determinants to Improve Chronic Kidney Disease Care
Status: Enrolling
Updated: 1/22/2013
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Comparison of Standard Versus Low Bicarbonate Hemodialysis
Intradialytic Acid-base Changes and Organic Anion Production With Standard Versus Low Bicarbonate Hemodialysis
Status: Enrolling
Updated:  1/24/2013
Montefiore Medical Center/Jack D. Weiler Hospital
mi
from
Bronx, NY
Comparison of Standard Versus Low Bicarbonate Hemodialysis
Intradialytic Acid-base Changes and Organic Anion Production With Standard Versus Low Bicarbonate Hemodialysis
Status: Enrolling
Updated: 1/24/2013
Montefiore Medical Center/Jack D. Weiler Hospital
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  1/28/2013
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 1/28/2013
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Click here to add this to my saved trials
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  1/28/2013
California Institue of Renal Research
mi
from
La Mesa, CA
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 1/28/2013
California Institue of Renal Research
mi
from
La Mesa, CA
Click here to add this to my saved trials
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  1/28/2013
Denver Nephrologists, PC
mi
from
Denver, CO
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 1/28/2013
Denver Nephrologists, PC
mi
from
Denver, CO
Click here to add this to my saved trials
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  1/28/2013
Renal Associates, P.A. Research Division
mi
from
San Antonio, TX
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 1/28/2013
Renal Associates, P.A. Research Division
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
Status: Enrolling
Updated:  1/29/2013
Johns Hopkins Medicine Suburban Hospital
mi
from
Bethesda, MD
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
Status: Enrolling
Updated: 1/29/2013
Johns Hopkins Medicine Suburban Hospital
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
Status: Enrolling
Updated:  1/29/2013
Greenville Memorial Hospital System University Medical Center
mi
from
Greenville, SC
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement
Status: Enrolling
Updated: 1/29/2013
Greenville Memorial Hospital System University Medical Center
mi
from
Greenville, SC
Click here to add this to my saved trials